Cassava Sciences | PTIE - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Abbott USD 4.24B 117M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Biogen USD 432M 18.9M 2025-12
Cara Therapeutics USD 4.08M 1.65M 2025-09
Cassava Sciences USD 41.65M 4.44M 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Geron USD 11.26M 146K 2025-12
J&J USD 10.46B 1.53B 2026-03
Merck USD 4.15B 102M 2025-09
Novartis USD 4.46B 99M 2025-12
Novavax USD 24.58M 9.35M 2025-12
Pfizer USD 5.02B 142M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12